These soluble protein agonists can replicate Notch activation in suspension culture, opening the door to scalable T-cell therapies.

Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...

Novel allogeneic stem cells and differentiated iPSCs are providing more physiologically relevant disease models.

It is already well-known that when a mother experiences inflammation during pregnancy, her child is more likely to develop ...

Trailhead Biosystems, Inc. (TrailBio.com), a biotechnology company advancing scalable human cell models derived from induced ...

Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key role in regulating ...

Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new ...

It is already well-known that when a mother experiences inflammation during pregnancy, her child is more likely to develop allergic diseases. Recently, a KAIST research team became the first in the ...

Key Points GAAP revenue surged to $4.0 million in Q2 2025, beating analyst expectations by 381.9%. GAAP net loss per share improved to $(0.50) in Q2 2025, slightly better than the estimated $(0.52).

The Fund returned approximately +14% during the second quarter, bringing our YTD returns to under +1%. Read more here.

It is already well-known that when a mother experiences inflammation during pregnancy, her child is more likely to develop ...

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...